This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
account_circleSign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Lamotrigine and blood dyscrasias

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • various blood dyscrasias have been reported associated with the use of lamotrigine world-wide

  • assessment of individual reports indicates that lamotrigine is likely to be the causative factor in the reported cases of blood dyscrasias associated with use of lamotrigine

  • routine FBC monitoring is not, at present, recommended in patients treated with lamotrigine

Check the summary of product characteristics before prescribing this drug.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.